Bethany Torr

May 4, 2024 | medrxiv.org | Bethany Torr |Christopher Jones |Grace Kavanaugh |Monica Hamill

ZK declares honoraria for educational resources and advisory board, AstraZeneca. No further conflicts of interest are reported by the authors. NCT04842799This study was funded by Cancer Research UK [C61296/A29423]. This study represents independent research supported by the National Institute for Health and Care Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, London.

May 10, 2023 | thelancet.com | Smith-Byrne K |Catherine Huntley |Bethany Torr |Amit Sud

SummaryBackgroundIt is proposed that, through restriction to individuals delineated as high risk, polygenic risk scores (PRSs) might enable more efficient targeting of existing cancer screening programmes and enable extension into new age ranges and disease types.